Cite
APA Citation
Matsubara, N., Yonese, J., Kojima, T., Azuma, H., Matsumoto, H., Powles, T., Rosenberg, J. E., Petrylak, D. P., Matsangou, M., Wu, C., Campbell, M., & Yamashiro, M. (2023). japanese subgroup analysis of EV‐301: An open‐label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma. Cancer medicine, 12, 2761–2771. http://access.bl.uk/ark:/81055/vdc_100179401686.0x000013